Quoin Pharmaceuticals Ltd.
QNRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671502
In the last 90 days, Quoin Pharmaceuticals Ltd. insiders filed 4 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $6.29M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Quoin Pharmaceuticals Ltd. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −1 vs. Q2 2022
- Shares held
- 121.7K
- −48.2K (−28.4%) vs. Q2 2022
- Total value
- $272.0K
- −$49.0K (−15.3%) vs. Q2 2022
- New holders
- 5
- 1 more added
- Sold out
- 6
- 1 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $6.29M |
| Q1 2026 | 21 | $7.82M |
| Q4 2025 | 18 | $12.2M |
| Q3 2025 | 4 | $10.7K |
| Q2 2025 | 6 | $23.4K |
| Q1 2025 | 10 | $90.2K |
| Q4 2024 | 14 | $1.01M |
| Q3 2024 | 7 | $82.2K |
| Q2 2024 | 10 | $127.7K |
| Q1 2024 | 8 | $183.2K |
| Q4 2023 | 3 | $105.6K |
| Q3 2023 | 3 | $7.21K |
| Q2 2023 | 2 | $24.0K |
| Q1 2023 | 4 | $81.1K |
| Q4 2022 | 4 | $52.0K |
| Q3 2022 | 7 | $272.0K |
| Q2 2022 | 8 | $321.0K |
| Q1 2022 | 6 | $419.0K |
| Q4 2021 | 7 | $383.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Quoin Pharmaceuticals Ltd.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ground Swell Capital, LLC | 36,630 | $82.0K | 0.23% | +36,630 | New |
| Virtu Financial LLC | 29,865 | $67.0K | 0.01% | +29,865 | New |
| Citadel Advisors LLC | 17,614 | $39.0K | 0.00% | −1,968−10.1% | Reduced |
| Susquehanna International Group, LLP | 15,366 | $34.0K | 0.00% | +15,366 | New |
| Jane Street Group, LLC | 11,609 | $26.0K | 0.00% | +11,609 | New |
| UBS Group AG | 10,558 | $24.0K | 0.00% | +884+9.1% | Added |
| Morgan Stanley | 79 | $0 | 0.00% | +79 | New |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −64,932−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,108−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −14,392−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,229−100.0% | Sold out |